NEW YORK, March 29 (GenomeWeb News) - The Cambridge-MIT Institute said last week that it is launching a new initiative to bring researchers from different disciplines together to help accelerate advances in drug discovery.
CMI said it is funding the Next-Generation Drug Discovery Community, which will unite
According to CMI, the alliance will work on new methods of overcoming bottlenecks in the drug discovery and development process. The effort is designed to advance the development of techniques for the rapid and quantitative experimental measurement of the gene- and protein-level properties of cells and tissues simultaneously, as well as to offer computer-aided analysis of the meaning of these data.
The community's first projects will involve studying adult blood stem cells as experimental systems for testing the efficacy and toxicity of drugs, and establishing new computational methods to identify drug targets, said CMI.